home > drugs a-z list > recombinate (antihemophilic factor (recombinant)) drug center > recombinate (antihemophilic factor (recombinant)) drug - medication guide and patient information

The patient and physician should discuss the risks and benefits of this product.

Although allergic type hypersensitivity reactions were not observed in any patient receiving RECOMBINATE (antihemophilic factor (recombinant)) rAHF on study, such reactions are theoretically possible. Patients should be informed of the early signs of hypersensitivity reactions including hives, generalized urticaria, tightness of the chest, wheezing, hypotension, and anaphylaxis. Patients should be advised to discontinue use of the product and contact their physician if these symptoms occur.

Last reviewed on RxList: 2/20/2009
This monograph has been modified to include the generic and brand name in many instances.